Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 91

1.

Dataset on statistical analysis of jet A-1 fuel laboratory properties for on-spec into-plane operations.

Adekitan AI, Shomefun T, John TM, Adetokun B, Aligbe A.

Data Brief. 2018 May 23;19:826-834. doi: 10.1016/j.dib.2018.05.083. eCollection 2018 Aug.

2.

Dataset showing steel cold rolling process parameters for a 6-high cold rolling mill in Nigeria.

Ayuba EO, Bolu CA, John TM, Abioye AA.

Data Brief. 2018 Mar 22;18:891-901. doi: 10.1016/j.dib.2018.03.081. eCollection 2018 Jun.

3.

Datasets linking ethnic perceptions to undergraduate students learning outcomes in a Nigerian Tertiary Institution.

Badejo JA, John TM, Omole DO, Ucheaga EG, Popoola SI, Odukoya JA, Ajayi PO, Aboyade M, Atayero AA.

Data Brief. 2018 Mar 22;18:760-764. doi: 10.1016/j.dib.2018.03.069. eCollection 2018 Jun.

4.

The role of gender on academic performance in STEM-related disciplines: Data from a tertiary institution.

John TM, Badejo JA, Popoola SI, Omole DO, Odukoya JA, Ajayi PO, Aboyade M, Atayero AA.

Data Brief. 2018 Mar 17;18:360-374. doi: 10.1016/j.dib.2018.03.052. eCollection 2018 Jun.

5.

Learning analytics: Dataset for empirical evaluation of entry requirements into engineering undergraduate programs in a Nigerian university.

Odukoya JA, Popoola SI, Atayero AA, Omole DO, Badejo JA, John TM, Olowo OO.

Data Brief. 2018 Feb 15;17:998-1014. doi: 10.1016/j.dib.2018.02.025. eCollection 2018 Apr.

6.

Learning analytics for smart campus: Data on academic performances of engineering undergraduates in Nigerian private university.

Popoola SI, Atayero AA, Badejo JA, John TM, Odukoya JA, Omole DO.

Data Brief. 2018 Jan 3;17:76-94. doi: 10.1016/j.dib.2017.12.059. eCollection 2018 Apr.

7.

Quantitative Thresholds Enable Accurate Identification of Clostridium difficile Infection by the Luminex xTAG Gastrointestinal Pathogen Panel.

Leal SM Jr, Popowitch EB, Levinson KJ, John TM, Lehman B, Rios MB, Gilligan PH, Miller MB.

J Clin Microbiol. 2018 May 25;56(6). pii: e01885-17. doi: 10.1128/JCM.01885-17. Print 2018 Jun.

8.

Geographic tongue.

Jacob CN, John TM, R J.

Cleve Clin J Med. 2016 Aug;83(8):565-6. doi: 10.3949/ccjm.83a.14011. No abstract available.

9.

Persistence of specific bactericidal antibodies at 5 years of age after vaccination against serogroup B meningococcus in infancy and at 40 months.

McQuaid F, Snape MD, John TM, Kelly S, Robinson H, Yu LM, Toneatto D, D'Agostino D, Dull PM, Pollard AJ.

CMAJ. 2015 Apr 21;187(7):E215-E223. doi: 10.1503/cmaj.141200. Epub 2015 Mar 23.

10.

Meningococcal carriage in adolescents in the United Kingdom to inform timing of an adolescent vaccination strategy.

Jeppesen CA, Snape MD, Robinson H, Gossger N, John TM, Voysey M, Ladhani S, Okike IO, Oeser C, Kent A, Oliver J, Taylor P, Morales-Aza B, Clarke SC, Casey M, Martins F, Kitchin NR, Anderson AS, Jones H, Jansen KU, Eiden J, Pedneault L, Heath PT, Finn A, Faust SN, Pollard AJ.

J Infect. 2015 Jul;71(1):43-52. doi: 10.1016/j.jinf.2015.02.006. Epub 2015 Feb 21.

11.

Persistence of bactericidal antibodies to 5 years of age after immunization with serogroup B meningococcal vaccines at 6, 8, 12 and 40 months of age.

McQuaid F, Snape MD, John TM, Kelly S, Robinson H, Houlden J, Voysey M, Toneatto D, Kitte C, Dull PM, Pollard AJ.

Pediatr Infect Dis J. 2014 Jul;33(7):760-6. doi: 10.1097/INF.0000000000000327.

PMID:
24722351
12.

Long-term persistence of immunity and B-cell memory following Haemophilus influenzae type B conjugate vaccination in early childhood and response to booster.

Perrett KP, John TM, Jin C, Kibwana E, Yu LM, Curtis N, Pollard AJ.

Clin Infect Dis. 2014 Apr;58(7):949-59. doi: 10.1093/cid/ciu001. Epub 2014 Jan 7.

PMID:
24403544
13.

Persistence of bactericidal antibodies following early infant vaccination with a serogroup B meningococcal vaccine and immunogenicity of a preschool booster dose.

Snape MD, Saroey P, John TM, Robinson H, Kelly S, Gossger N, Yu LM, Wang H, Toneatto D, Dull PM, Pollard AJ.

CMAJ. 2013 Oct 15;185(15):E715-24. doi: 10.1503/cmaj.130257. Epub 2013 Sep 23.

14.

Bactericidal antibody persistence 2 years after immunization with 2 investigational serogroup B meningococcal vaccines at 6, 8 and 12 months and immunogenicity of preschool booster doses: a follow-on study to a randomized clinical trial.

Snape MD, Philip J, John TM, Robinson H, Kelly S, Gossger N, Yu LM, Kittel C, Toneatto D, Dull PM, Pollard AJ.

Pediatr Infect Dis J. 2013 Oct;32(10):1116-21. doi: 10.1097/INF.0b013e31829cfff2.

PMID:
23958808
15.

Genetic material should be routinely collected in clinical vaccine trials--high consent rates can be achieved across all age groups.

Trück J, O'Connor D, Darton TC, John TM, Snape MD, Pollard AJ.

Vaccine. 2013 Jun 7;31(25):2744-8. doi: 10.1016/j.vaccine.2013.03.070. Epub 2013 Apr 24.

PMID:
23623856
16.

A case of acute onset parkinsonism.

John TM, Jacob CN, Xavier J, Kondanath S, Ittycheria CC, Jayaprakash R.

Qatar Med J. 2013 Dec 23;2013(2):29-32. doi: 10.5339/qmj.2013.12. eCollection 2013.

17.

B cell memory to a serogroup C meningococcal conjugate vaccine in childhood and response to booster: little association with serum IgG antibody.

Perrett KP, Jin C, Clutterbuck E, John TM, Winter AP, Kibwana E, Yu LM, Curtis N, Pollard AJ.

J Immunol. 2012 Sep 1;189(5):2673-81. doi: 10.4049/jimmunol.1200451. Epub 2012 Aug 1.

18.

Persistence of antibody response following a booster dose of Hib-MenC-TT glycoconjugate vaccine to five years: a follow-up study.

Khatami A, Snape MD, Wysocki J, John TM, Westcar S, Mesaros N, Peddiraju K, Boutriau D, Yu LM, Pollard AJ.

Pediatr Infect Dis J. 2012 Oct;31(10):1069-73. doi: 10.1097/INF.0b013e318262528c.

PMID:
22673139
19.

Evaluation of haemophilus influenzae type b vaccine for routine immunization in Nepali infants.

Metz JA, Hanieh S, Pradhan R, Joshi A, Shakya D, Shrestha L, Shrestha A, Upadhyay B, Kelly SC, John TM, Maharjan BD, Yu LM, Omar O, Borrow R, Findlow J, Kelly DF, Thorson SM, Adhikari N, Murdoch DR, Pollard AJ.

Pediatr Infect Dis J. 2012 Apr;31(4):e66-72. doi: 10.1097/INF.0b013e31824a9c37.

PMID:
22418662
20.

Macrophage activation syndrome following Acinetobacter baumannii sepsis.

John TM, Jacob CN, Ittycheria CC, George AM, Jacob AG, Subramaniyam S, Puthiyaveettil J, Jayaprakash R.

Int J Infect Dis. 2012 Mar;16(3):e223-4. doi: 10.1016/j.ijid.2011.12.002. Epub 2012 Jan 27.

21.

H1N1 antibody persistence 1 year after immunization with an adjuvanted or whole-virion pandemic vaccine and immunogenicity and reactogenicity of subsequent seasonal influenza vaccine: a multicenter follow-on study.

Walker WT, de Whalley P, Andrews N, Oeser C, Casey M, Michaelis L, Hoschler K, Harrill C, Moulsdale P, Thompson B, Jones C, Chalk J, Kerridge S, John TM, Okike I, Ladhani S, Tomlinson R, Heath PT, Miller E, Faust SN, Snape MD, Finn A, Pollard AJ.

Clin Infect Dis. 2012 Mar 1;54(5):661-9. doi: 10.1093/cid/cir905. Epub 2012 Jan 19.

22.

Persistence of serum bactericidal antibody one year after a booster dose of either a glycoconjugate or a plain polysaccharide vaccine against serogroup C Neisseria meningitidis given to adolescents previously immunized with a glycoconjugate vaccine.

de Whalley PC, Snape MD, Kelly DF, Banner C, Lewis S, Diggle L, John TM, Yu LM, Omar O, Borkowski A, Pollard AJ.

Pediatr Infect Dis J. 2011 Nov;30(11):e203-8. doi: 10.1097/INF.0b013e318224fb14.

PMID:
21673612
23.

Immunogenicity and reactogenicity of a 13-valent-pneumococcal conjugate vaccine administered at 2, 4, and 12 months of age: a double-blind randomized active-controlled trial.

Snape MD, Klinger CL, Daniels ED, John TM, Layton H, Rollinson L, Pestridge S, Dymond S, Galiza E, Tansey S, Scott DA, Baker SA, Jones TR, Yu LM, Gruber WC, Emini EA, Faust SN, Finn A, Heath PT, Pollard AJ.

Pediatr Infect Dis J. 2010 Dec;29(12):e80-90.

PMID:
21155091
24.

Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant Meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy.

Findlow J, Borrow R, Snape MD, Dawson T, Holland A, John TM, Evans A, Telford KL, Ypma E, Toneatto D, Oster P, Miller E, Pollard AJ.

Clin Infect Dis. 2010 Nov 15;51(10):1127-37. doi: 10.1086/656741. Epub 2010 Oct 18.

PMID:
20954968
25.

Immunogenicity of two investigational serogroup B meningococcal vaccines in the first year of life: a randomized comparative trial.

Snape MD, Dawson T, Oster P, Evans A, John TM, Ohene-Kena B, Findlow J, Yu LM, Borrow R, Ypma E, Toneatto D, Pollard AJ.

Pediatr Infect Dis J. 2010 Nov;29(11):e71-9. doi: 10.1097/INF.0b013e3181f59f6d.

PMID:
20844462
26.

Pseudomyxoma peritonei.

Anoop TM, John TM, Fukunaga N.

Indian J Surg. 2010 Jul;72(Suppl 1):353-4. doi: 10.1007/s12262-010-0109-1. Epub 2010 Oct 20. No abstract available.

27.

Antibody persistence after serogroup C meningococcal conjugate immunization of United Kingdom primary-school children in 1999-2000 and response to a booster: a phase 4 clinical trial.

Perrett KP, Winter AP, Kibwana E, Jin C, John TM, Yu LM, Borrow R, Curtis N, Pollard AJ.

Clin Infect Dis. 2010 Jun 15;50(12):1601-10. doi: 10.1086/652765.

PMID:
20459323
28.

Immunogenicity and immune memory of a nonadjuvanted quadrivalent meningococcal glycoconjugate vaccine in infants.

Perrett KP, Snape MD, Ford KJ, John TM, Yu LM, Langley JM, McNeil S, Dull PM, Ceddia F, Anemona A, Halperin SA, Dobson S, Pollard AJ.

Pediatr Infect Dis J. 2009 Mar;28(3):186-93. doi: 10.1097/INF.0b013e31818e037d.

PMID:
19209097
29.

Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial.

Snape MD, Perrett KP, Ford KJ, John TM, Pace D, Yu LM, Langley JM, McNeil S, Dull PM, Ceddia F, Anemona A, Halperin SA, Dobson S, Pollard AJ.

JAMA. 2008 Jan 9;299(2):173-84. doi: 10.1001/jama.2007.29-c. Erratum in: JAMA. 2011 Mar 16;305(11):1096.

PMID:
18182599
30.

Pyrroloquinolone PDE5 inhibitors with improved pharmaceutical profiles for clinical studies on erectile dysfunction.

Jiang W, Guan J, Macielag MJ, Zhang S, Qiu Y, Kraft P, Bhattacharjee S, John TM, Haynes-Johnson D, Lundeen S, Sui Z.

J Med Chem. 2005 Mar 24;48(6):2126-33.

PMID:
15771456
31.

Synthesis and SAR of tetracyclic pyrroloquinolones as phosphodiesterase 5 inhibitors.

Jiang W, Alford VC, Qiu Y, Bhattacharjee S, John TM, Haynes-Johnson D, Kraft PJ, Lundeen SG, Sui Z.

Bioorg Med Chem. 2004 Mar 15;12(6):1505-15.

PMID:
15018924
32.

Taking a bite out of policies: a look at the policies affecting our nation's dental health.

Gorbova M, John TM.

J Pediatr Nurs. 2004 Feb;19(1):51-7. Review. No abstract available.

PMID:
14963870
33.

Structure-activity relationships of N-acyl pyrroloquinolone PDE-5 inhibitors.

Lanter JC, Sui Z, Macielag MJ, Fiordeliso JJ, Jiang W, Qiu Y, Bhattacharjee S, Kraft P, John TM, Haynes-Johnson D, Craig E, Clancy J.

J Med Chem. 2004 Jan 29;47(3):656-62.

PMID:
14736245
34.

Characterization of a novel phosphodiesterase type 5 inhibitor: JNJ-10258859.

Qiu Y, Bhattacharjee S, Kraft P, John TM, Craig E, Haynes-Johnson D, Guan J, Jiang W, Macielag M, Sui Z, Clancy J, Lundeen S.

Eur J Pharmacol. 2003 Jul 4;472(1-2):73-80.

PMID:
12860475
35.

Synthesis and biological activities of novel beta-carbolines as PDE5 inhibitors.

Sui Z, Guan J, Macielag MJ, Jiang W, Qiu Y, Kraft P, Bhattacharjee S, John TM, Craig E, Haynes-Johnson D, Clancy J.

Bioorg Med Chem Lett. 2003 Feb 24;13(4):761-5.

PMID:
12639576
36.

Furoyl and benzofuroyl pyrroloquinolones as potent and selective PDE5 inhibitors for treatment of erectile dysfunction.

Jiang W, Sui Z, Macielag MJ, Walsh SP, Fiordeliso JJ, Lanter JC, Guan J, Qiu Y, Kraft P, Bhattacharjee S, Craig E, Haynes-Johnson D, John TM, Clancy J.

J Med Chem. 2003 Jan 30;46(3):441-4.

PMID:
12540243
37.

Pyrimidinylpyrroloquinolones as highly potent and selective PDE5 inhibitors for treatment of erectile dysfunction.

Sui Z, Guan J, Macielag MJ, Jiang W, Zhang S, Qiu Y, Kraft P, Bhattacharjee S, John TM, Haynes-Johnson D, Clancy J.

J Med Chem. 2002 Sep 12;45(19):4094-6.

PMID:
12213052
38.

Differentiating between parthenogenetic and "positive development" embryos in turkeys by molecular sexing.

Cassar G, Mohammed M, John TM, Gazdzinski P, Etches RJ.

Poult Sci. 1998 Oct;77(10):1463-8.

PMID:
9776051
39.

Observations on ploidy of cells and on reproductive performance in parthenogenetic turkeys.

Cassar G, John TM, Etches RJ.

Poult Sci. 1998 Oct;77(10):1457-62.

PMID:
9776050
40.

60 Hz magnetic field exposure and urinary 6-sulphatoxymelatonin levels in the rat.

John TM, Liu GY, Brown GM.

Bioelectromagnetics. 1998;19(3):172-80.

PMID:
9554695
41.

Effects of exogenous arginine vasotocin on circulating levels of thyroid hormones and melatonin in the pigeon, Columbia livia.

John TM, George JC, Brown GM.

Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. 1995 Nov;112(3):345-51.

PMID:
8838688
42.

Melatonin replacement nullifies the effect of light-induced functional pinealectomy on nociceptive rhythm in the rat.

John TM, Brown MC, Wideman L, Brown GM.

Physiol Behav. 1994 Apr;55(4):735-9.

PMID:
8190803
44.

Effects of arginine vasotocin on cardiorespiratory and thermoregulatory responses in the pigeon.

John TM, George JC.

Comp Biochem Physiol C. 1992 Jul;102(3):353-9.

PMID:
1360346
45.

Flight effects on plasma levels of neurohypophysial hormones in homing pigeons.

George JC, John TM, Koike TI.

Biol Signals. 1992 May-Jun;1(3):160-6.

PMID:
1307921
46.
47.
48.

Flight effects on plasma levels of lipid, glucagon and thyroid hormones in homing pigeons.

George JC, John TM, Mitchell MA.

Horm Metab Res. 1989 Oct;21(10):542-5.

PMID:
2807143
49.

Circulating levels of insulin and avian pancreatic polypeptide in pigeons under different experimental conditions.

John TM, Pilo B, Hazelwood RL, George JC.

Gen Comp Endocrinol. 1989 Jul;75(1):71-7.

PMID:
2670661
50.

Seasonal ultrastructural changes in the pineal gland of the migratory Canada goose.

John TM, George JC.

Cytobios. 1989;58(234-35):179-204.

PMID:
2591254

Supplemental Content

Support Center